Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pratap Parida, Shovonlal Bhowmick, Achintya Saha & Md Ataul Islam. (2021) Insight into the screening of potential beta-lactamase inhibitors as anti-bacterial chemical agents through pharmacoinformatics study. Journal of Biomolecular Structure and Dynamics 39:3, pages 923-942.
Read now
Read now
Sako Mirzaie, Kambiz Najafi, Mohammad Saeed Hakhamaneshi, Ahmad Reza Shahverdi & Fardin Fathi. (2015) Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies. Journal of Biomolecular Structure and Dynamics 33:5, pages 1016-1026.
Read now
Read now
Matteo Bassetti, Francesca Ginocchio, Małgorzata Mikulska, Lucia Taramasso & Daniele Roberto Giacobbe. (2011) Will new antimicrobials overcome resistance among Gram-negatives?. Expert Review of Anti-infective Therapy 9:10, pages 909-922.
Read now
Read now
Gina Devasahayam, William M Scheld & Paul S Hoffman. (2010) Newer antibacterial drugs for a new century. Expert Opinion on Investigational Drugs 19:2, pages 215-234.
Read now
Read now
Articles from other publishers (31)
Wen‐Hao Deng & Rong‐Zhen Liao. (2022)
Sequential C−H Methylation Catalyzed by the B
12
‐Dependent SAM Enzyme TokK: Comprehensive Theoretical Study of Selectivities
. Chemistry – A European Journal 29:7.
Crossref
Crossref
Rehab H. Abd El-Aleam, Riham F. George, Hanan H. Georgey & Hamdy M. Abdel-Rahman. (2021) Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance. RSC Advances 11:58, pages 36459-36482.
Crossref
Crossref
M Shamim Hasan Zahid, Devika M Varma, Monica M Johnson, Antonio Landavazo, Eric M Bachelder, Bruce E Blough & Kristy M Ainslie. (2021)
Overcoming reduced antibiotic susceptibility in intracellular
Salmonella enterica
serovar Typhimurium using AR-12
. FEMS Microbiology Letters 368:11.
Crossref
Crossref
Payam Behzadi, Zoltán Baráth & Márió Gajdács. (2021) It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 10:1, pages 42.
Crossref
Crossref
Kamya Bhatnagar, Aaron Hinz, Melissa Kohlman & Alex Wong. (2020)
An sRNA Screen for Reversal of Quinolone Resistance in
Escherichia coli
. G3 Genes|Genomes|Genetics 10:1, pages 79-88.
Crossref
Crossref
Janusz J. Petkowski, William BainsSara Seager. (2018) Natural Products Containing a Nitrogen–Sulfur Bond. Journal of Natural Products 81:2, pages 423-446.
Crossref
Crossref
Aleksandar M. Veselinović, Andrey Toropov, Alla Toropova, Dobrila Stanković-Đorđević & Jovana B. Veselinović. (2018)
Design and development of novel antibiotics based on FtsZ inhibition –
in silico
studies
. New Journal of Chemistry 42:13, pages 10976-10982.
Crossref
Crossref
Olga Lomovskaya, Dongxu Sun, Debora Rubio-Aparicio, Kirk Nelson, Ruslan Tsivkovski, David C. Griffith & Michael N. Dudley. (2017) Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 61:11.
Crossref
Crossref
Kambiz Davari, Jamileh Nowroozi, Farzaneh Hosseini, Abbas Akhavan Sepahy & Sako Mirzaie. (2017) Structure-based virtual screening to identify the beta-lactamase CTX-M-9 inhibitors: An in silico effort to overcome antibiotic resistance in E. coli. Computational Biology and Chemistry 67, pages 174-181.
Crossref
Crossref
Kuldipsinh P. Barot, Kuntal S. Manna & Manjunath D. Ghate. (2017) Design, synthesis and antimicrobial activities of some novel 1,3,4-thiadiazole, 1,2,4-triazole-5-thione and 1,3-thiazolan-4-one derivatives of benzimidazole. Journal of Saudi Chemical Society 21, pages S35-S43.
Crossref
Crossref
Douglas J. Biedenbach, Krystyna Kazmierczak, Samuel K. Bouchillon, Daniel F. Sahm & Patricia A. Bradford. (2015)
In Vitro
Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
. Antimicrobial Agents and Chemotherapy 59:7, pages 4239-4248.
Crossref
Crossref
Joseph Buensalido, Carmen DeMarco & Stephen Lerner. 2015. Practical Handbook of Microbiology, Third Edition. Practical Handbook of Microbiology, Third Edition
153
182
.
Richard J. FairYitzhak Tor. (2014) Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in Medicinal Chemistry 6, pages PMC.S14459.
Crossref
Crossref
Sowmya Pazhur Mohandas, Sita Ravikumar, Sumi J Menachery, Gayathri Suseelan, Sai Shyam Narayanan, Hemaraj Nandanwar & Kesavan Madhavan Nampoothiri. (2012) Bioactives of Microbes Isolated from Western Ghat Belt of Kerala Show ?-Lactamase Inhibition along with Wide Spectrum Antimicrobial Activity. Applied Biochemistry and Biotechnology 167:6, pages 1753-1762.
Crossref
Crossref
Takushi Kaneko, Christopher Cooper & Khisimuzi Mdluli. (2011) Challenges and opportunities in developing novel drugs for TB. Future Medicinal Chemistry 3:11, pages 1373-1400.
Crossref
Crossref
Joseph D. C. Yao & Robert C. MoelleringJr.Jr.. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology
1041
1081
.
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto Giacobbe & Malgorzata Mikulska. (2011) Development of antibiotics for Gram-negatives: where now?. Clinical Investigation 1:2, pages 211-227.
Crossref
Crossref
Matteo Bassetti, Francesca Ginocchio & Malgorzata Mikulska. (2011) New treatment options against gram-negative organisms. Critical Care 15:2, pages 215.
Crossref
Crossref
David M. Livermore, Shazad Mushtaq, Marina Warner, Jiancheng Zhang, Sunil Maharjan, Michel Doumith & Neil Woodford. (2011)
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing
Enterobacteriaceae
. Antimicrobial Agents and Chemotherapy 55:1, pages 390-394.
Crossref
Crossref
M. Bassetti, F. Ginocchio & M. Mikulska. 2011. Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011
501
515
.
Thérèse Stachyra, Marie-Claude Péchereau, Jean-Michel Bruneau, Monique Claudon, Jean-Marie Frère, Christine Miossec, Kenneth Coleman & Michael T. Black. (2010) Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor. Antimicrobial Agents and Chemotherapy 54:12, pages 5132-5138.
Crossref
Crossref
Melanie J. StablesJustine NewsonSamir S. Ayoub, Jeremy Brown, Catherine J. Hyams & Derek W. Gilroy. (2010) Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria. Blood 116:16, pages 2950-2959.
Crossref
Crossref
Michael C. FlickingerAndria L. Deaguero, Janna K. Blum & Andreas S. Bommarius. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology.
Sarah M. Drawz & Robert A. Bonomo. (2010) Three Decades of β-Lactamase Inhibitors. Clinical Microbiology Reviews 23:1, pages 160-201.
Crossref
Crossref
Stephen J BakerCharles Z DingTsutomu AkamaYong-Kang ZhangVincent HernandezYi Xia. (2009) Therapeutic potential of boron-containing compounds. Future Medicinal Chemistry 1:7, pages 1275-1288.
Crossref
Crossref
Sudipta Majumdar & R. F. Pratt. (2009) Inhibition of Class A and C β-Lactamases by Diaroyl Phosphates. Biochemistry 48:35, pages 8285-8292.
Crossref
Crossref
Kenneth V.I. Rolston. (2009) The Use of New and Better Antibiotics for Bacterial Infections in Patients With Leukemia. Clinical Lymphoma and Myeloma 9, pages S357-S363.
Crossref
Crossref
Kenneth V. I. Rolston. (2009) New antimicrobial agents for the treatment of bacterial infections in cancer patients. Hematological Oncology 27:3, pages 107-114.
Crossref
Crossref
Andrea Endimiani, Yuvraj Choudhary & Robert A. Bonomo. (2009) In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases. Antimicrobial Agents and Chemotherapy 53:8, pages 3599-3601.
Crossref
Crossref
Peter J. Petersen, C. Hal Jones, Aranapakam M. Venkatesan & Patricia A. Bradford. (2009) Efficacy of Piperacillin Combined with the Penem β-Lactamase Inhibitor BLI-489 in Murine Models of Systemic Infection. Antimicrobial Agents and Chemotherapy 53:4, pages 1698-1700.
Crossref
Crossref
Peter J. Petersen, C. Hal Jones, Aranapakam M. Venkatesan, Tarek S. Mansour, Steven J. Projan & Patricia A. Bradford. (2009) Establishment of In Vitro Susceptibility Testing Methodologies and Comparative Activities of Piperacillin in Combination with the Penem β-Lactamase Inhibitor BLI-489. Antimicrobial Agents and Chemotherapy 53:2, pages 370-384.
Crossref
Crossref